Literature DB >> 9150142

Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition.

G T van der Horst1, H van Steeg, R J Berg, A J van Gool, J de Wit, G Weeda, H Morreau, R B Beems, C F van Kreijl, F R de Gruijl, D Bootsma, J H Hoeijmakers.   

Abstract

A mouse model for the nucleotide excision repair disorder Cockayne syndrome (CS) was generated by mimicking a truncation in the CSB(ERCC6) gene of a CS-B patient. CSB-deficient mice exhibit all of the CS repair characteristics: ultraviolet (UV) sensitivity, inactivation of transcription-coupled repair, unaffected global genome repair, and inability to resume RNA synthesis after UV exposure. Other CS features thought to involve the functioning of basal transcription/repair factor TFIIH, such as growth failure and neurologic dysfunction, are present in mild form. In contrast to the human syndrome, CSB-deficient mice show increased susceptibility to skin cancer. Our results demonstrate that transcription-coupled repair of UV-induced cyclobutane pyrimidine dimers contributes to the prevention of carcinogenesis in mice. Further, they suggest that the lack of cancer predisposition in CS patients is attributable to a global genome repair process that in humans is more effective than in rodents.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150142     DOI: 10.1016/s0092-8674(00)80223-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  106 in total

1.  Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis.

Authors:  J Y Tang; B J Hwang; J M Ford; P C Hanawalt; G Chu
Journal:  Mol Cell       Date:  2000-04       Impact factor: 17.970

2.  DNA repair on the brain.

Authors:  R R Laposa; J E Cleaver
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

3.  Human longevity and variation in GH/IGF-1/insulin signaling, DNA damage signaling and repair and pro/antioxidant pathway genes: cross sectional and longitudinal studies.

Authors:  Mette Soerensen; Serena Dato; Qihua Tan; Mikael Thinggaard; Rabea Kleindorp; Marian Beekman; Rune Jacobsen; H Eka D Suchiman; Anton J M de Craen; Rudi G J Westendorp; Stefan Schreiber; Tinna Stevnsner; Vilhelm A Bohr; P Eline Slagboom; Almut Nebel; James W Vaupel; Kaare Christensen; Matt McGue; Lene Christiansen
Journal:  Exp Gerontol       Date:  2012-03-03       Impact factor: 4.032

Review 4.  Cockayne syndrome group B cellular and biochemical functions.

Authors:  Cecilie Löe Licht; Tinna Stevnsner; Vilhelm A Bohr
Journal:  Am J Hum Genet       Date:  2003-11-24       Impact factor: 11.025

Review 5.  Cockayne syndrome: defective repair of transcription?

Authors:  A J van Gool; G T van der Horst; E Citterio; J H Hoeijmakers
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

6.  Initiation of DNA repair mediated by a stalled RNA polymerase IIO.

Authors:  Jean-Philippe Lainé; Jean-Marc Egly
Journal:  EMBO J       Date:  2006-01-12       Impact factor: 11.598

7.  Cockayne syndrome group B (Csb) and group a (Csa) deficiencies predispose to hearing loss and cochlear hair cell degeneration in mice.

Authors:  A Paul Nagtegaal; Robert N Rainey; Ingrid van der Pluijm; Renata M C Brandt; Gijsbertus T J van der Horst; J Gerard G Borst; Neil Segil
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

8.  Epistatic SNP interaction of ERCC6 with ERCC8 and their joint protein expression contribute to gastric cancer/atrophic gastritis risk.

Authors:  Jing-Jing Jing; You-Zhu Lu; Li-Ping Sun; Jing-Wei Liu; Yue-Hua Gong; Qian Xu; Nan-Nan Dong; Yuan Yuan
Journal:  Oncotarget       Date:  2017-06-27

Review 9.  Multiple interaction partners for Cockayne syndrome proteins: implications for genome and transcriptome maintenance.

Authors:  Maria D Aamann; Meltem Muftuoglu; Vilhelm A Bohr; Tinna Stevnsner
Journal:  Mech Ageing Dev       Date:  2013-04-09       Impact factor: 5.432

Review 10.  DNA repair deficiency and neurological disease.

Authors:  Peter J McKinnon
Journal:  Nat Rev Neurosci       Date:  2009-01-15       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.